HALOVSPFSA• 6 Months (Normalized)
HALO vs PFSA (Halozyme Therapeutics Inc. vs Profusa Inc.)
Showing Closing Date Range from Apr 8 to Oct 5, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
HALO Performance $109.86
+67.9%
Halozyme Therapeutics Inc.
Normalized Baseline0.00%
PFSA Performance $1.69
-98.61%
Profusa Inc.
Normalized Baseline0.00%
Alpha Spread Margin HALO LEADS
+166.51 pts
HALO outperforming by 166.51 percentage points
HALOPFSA
Spread Trajectory6 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
HALO PFSA
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(124 dates)
| Date | HALO Price | HALO Gain (%) | PFSA Price | PFSA Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 02, 2026 | $109.86 | +67.90% | $1.69 | -98.61% | +166.51% |
| Oct 01, 2026 | $106.94 | +63.44% | $- | - | |
| Sep 30, 2026 | $110.40 | +68.73% | $1.98 | -98.38% | +167.11% |
| Sep 29, 2026 | $111.56 | +70.50% | $2.27 | -98.14% | +168.64% |
| Sep 28, 2026 | $112.89 | +72.54% | $1.69 | -98.61% | +171.15% |
| Sep 25, 2026 | $113.90 | +74.08% | $2.18 | -98.21% | +172.29% |
| Sep 24, 2026 | $- | $3.03 | -97.52% | - | |
| Sep 23, 2026 | $112.44 | +71.85% | $2.05 | -98.32% | +170.17% |
| Sep 22, 2026 | $115.13 | +75.96% | $2.17 | -98.22% | +174.18% |
| Sep 21, 2026 | $111.45 | +70.33% | $1.94 | -98.41% | +168.74% |
| Sep 18, 2026 | $112.45 | +71.86% | $1.91 | -98.43% | +170.29% |
| Sep 17, 2026 | $109.68 | +67.63% | $1.80 | -98.52% | +166.15% |
| Sep 16, 2026 | $108.44 | +65.73% | $1.78 | -98.54% | +164.27% |
| Sep 15, 2026 | $106.25 | +62.39% | $1.83 | -98.50% | +160.89% |
| Sep 14, 2026 | $107.94 | +64.97% | $2.59 | -97.88% | +162.85% |
Page 1 of 9